See more : Joint Stock Company Kaspi.kz (KSPI.IL) Income Statement Analysis – Financial Results
Complete financial analysis of Balincan International Inc. (ALTB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Balincan International Inc., a leading company in the Auto – Dealerships industry within the Consumer Cyclical sector.
- Syndax Pharmaceuticals, Inc. (SNDX) Income Statement Analysis – Financial Results
- Guangdong Dongfang Precision Science & Technology Co., Ltd. (002611.SZ) Income Statement Analysis – Financial Results
- Stifel Financial Corporation 5.20% Senior Notes due 2047 (SFB) Income Statement Analysis – Financial Results
- Foresight Autonomous Holdings Ltd. (FRSX.TA) Income Statement Analysis – Financial Results
- Camtek Ltd. (CAMT) Income Statement Analysis – Financial Results
Balincan International Inc. (ALTB)
Industry: Auto - Dealerships
Sector: Consumer Cyclical
About Balincan International Inc.
Balincan International Inc. does not have significant operations. Previously, it operated a retail shop that sells skincare and cosmetic products in Hong Kong and China. The company was formerly known as Alpine Auto Brokers, Inc. and changed its name to Balincan International Inc. in July 2016. Balincan International Inc. was founded in 2010 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 146.95K | 0.00 | 0.00 | 0.00 | 171.63K | 359.52K | 402.89K |
| Cost of Revenue | 423.00 | 0.00 | 0.00 | 0.00 | 165.94K | 371.14K | 390.22K |
| Gross Profit | 146.53K | 0.00 | 0.00 | 0.00 | 5.69K | -11.61K | 12.67K |
| Gross Profit Ratio | 99.71% | 0.00% | 0.00% | 0.00% | 3.32% | -3.23% | 3.15% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 29.74K | 345.36K | 12.84K | 41.69K | 31.33K | 5.69K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.00K |
| SG&A | 180.89K | 29.74K | 345.36K | 12.84K | 41.69K | 31.33K | 31.69K |
| Other Expenses | 0.00 | 29.74K | 345.36K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 180.89K | 29.74K | 345.36K | 12.84K | 41.69K | 31.33K | 31.69K |
| Cost & Expenses | 181.31K | 29.74K | 345.36K | 12.84K | 207.63K | 402.47K | 421.91K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 | 11.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 423.00 | 29.74K | 345.36K | 12.84K | 36.00K | 42.95K | 19.02K |
| EBITDA | -33.94K | -29.74K | -345.36K | -12.84K | -36.00K | 0.00 | 11.00 |
| EBITDA Ratio | -23.09% | 0.00% | 0.00% | 0.00% | -20.98% | -11.94% | 0.00% |
| Operating Income | -34.36K | -29.74K | -345.36K | -12.84K | -36.00K | -42.95K | -19.02K |
| Operating Income Ratio | -23.38% | 0.00% | 0.00% | 0.00% | -20.98% | -11.94% | -4.72% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 | 11.00 |
| Income Before Tax | -34.36K | -29.74K | -345.36K | -12.84K | -36.00K | -42.93K | -19.01K |
| Income Before Tax Ratio | -23.38% | 0.00% | 0.00% | 0.00% | -20.98% | -11.94% | -4.72% |
| Income Tax Expense | -3.00 | -29.74K | -345.35K | -12.83K | -36.00K | -14.00 | 11.00 |
| Net Income | -34.36K | -29.74K | -345.36K | -12.84K | -36.00K | -42.93K | -19.01K |
| Net Income Ratio | -23.38% | 0.00% | 0.00% | 0.00% | -20.98% | -11.94% | -4.72% |
| EPS | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 455.50M | 445.50M | 44.55M | 44.55M | 4.05M | 3.00M | 3.00M |
| Weighted Avg Shares Out (Dil) | 455.50M | 445.50M | 44.55M | 44.55M | 4.05M | 4.05M | 3.00M |
Source: https://incomestatements.info
Category: Stock Reports